-Reuters
$100 Invested In EPAM Sys 10 Years Ago Would Be Worth This Much
EPAM Sys (NYSE:EPAM) has outperformed the market over the past 10 years by 18.93% on an annualized basis.
Related Posts
SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $34
SVB Leerink analyst Mani Foroohar maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and lowers the price target from $36 to $34.
Cortexyme Reports Its Atuzaginstat Slowed Cognitive Decline In Participants With Alzheimer’s, P. Gingivalis Infection In Phase 2/3 Trial
Evidence supports P. gingivalis as a driver of Alzheimer’s in easily identified patient population
Successful identification of target population and therapeutic dose inform next steps
SOUTH SAN FRANCISCO,
Challenges For Volkswagen’s New CEO, Tesla’s biggest EV Competitor
A diverse set of pressing issues await Volkswagen AG’s (OTC:VWAGY) newly christened CEO Oliver Blume, Bloomberg reports. The issues included listing Porsche AG…